Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Edwards Lifesciences Corporation · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $9.79B | $9.53B - $9.93B | $3.10B | $4.59 | 11 |
| Dec 2029 | $8.98B | $8.74B - $9.10B | $2.84B | $4.241 | 15 |
| Dec 2028 | $8.18B | $8.16B - $8.19B | $2.59B | $3.796 | 22 |
| Dec 2027 | $7.43B | $7.19B - $7.53B | $2.35B | $3.375 | 22 |
| Dec 2026 | $6.76B | $6.64B - $6.82B | $2.14B | $3.012 | 22 |
| Dec 2025 | $6.04B | $5.99B - $6.08B | $1.92B | $2.595 | 22 |
| Dec 2024 | $5.80B | $5.33B - $5.86B | $1.84B | $2.568 | 16 |
| Dec 2023 | $6.14B | $6.05B - $6.22B | $1.95B | $2.336 | 15 |
| Dec 2022 | $5.37B | $5.26B - $5.44B | $1.90B | $2.46 | 10 |
| Dec 2021 | $5.26B | $5.15B - $5.33B | $1.70B | $2.263 | 11 |
| Dec 2020 | $4.39B | $4.29B - $4.44B | $926.28M | $1.889 | 11 |
| Dec 2019 | $4.32B | $4.23B - $4.38B | $1.21B | $1.868 | 10 |